Geron's Stem Cell Program Sold in late 2011, the Geron Corp. announced that it would be discontinuing its stem cell research program, including an ongoing Phase 1 trial for a human embryonic stem cell (hESC) treatment for spinal cord injury. Nearly a year later, two former Geron CEOs expressed that their new company, the San Francisco-based BioTime, would..................
|
|
Scooped by
TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
onto #ALS AWARENESS #LouGehrigsDisease #PARKINSONS October 2, 2013 8:22 PM
|
Your new post is loading...